Archive: 06/10/2015

Guidelines developed for managing conflicts of interest

(HealthDay)—The Guidelines International Network has developed principles for disclosure and management of conflicts of interest (COIs) during the clinical practice guideline development process, according to a report published ...

Oct 6, 2015

0

3

Young cancer survivors often develop new malignancies

(HealthDay)—Teen and young adult cancer survivors are at increased risk for other cancers later in life, a new study reveals.

Oct 6, 2015

0

29

Acetaminophen given early doesn't cut ICU days

(HealthDay)—For intensive care unit (ICU) patients with fever due to probable infection, early administration of acetaminophen does not affect the number of ICU-free days, according to a study published online Oct. 5 in ...

Oct 6, 2015

0

5

Aristada approved for schizophrenia

(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.

Oct 6, 2015

Express Scripts to cover pricey new cholesterol treatments

The nation's biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year.

Oct 6, 2015

Upper-limb remote preconditioning no help in cardiac Sx

(HealthDay)—Upper-limb remote ischemic preconditioning (RIPC) is not beneficial for patients undergoing cardiac surgery, according to two studies published online Oct. 5 in the New England Journal of Medicine. The research ...

Oct 6, 2015

0

3

Optune device approved for newly diagnosed brain cancer

(HealthDay)—The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme, an aggressive brain cancer.

Oct 6, 2015